LOUISVILLE, Colo., Oct. 26, 2023 /PRNewswire/ -- Trio Health (Trio), a leading clinical data solution provider, has announced the appointment of Mia Nease as its Chief Commercial Officer (CCO). In this role, Nease will lead the advancement of Trio's commercialization strategy and oversee the development of innovative solutions to meet the evolving needs of Trio's life sciences clients and collaborators..

路易斯维尔，科罗拉多州，2023年10月26日/PRNewswire/-Trio-Health（Trio）是一家领先的临床数据解决方案提供商，已宣布任命Mia-Nease作为其首席商业官（CCO）。在这个角色中，Nease将领导Trio商业化战略的推进，并监督创新解决方案的开发，以满足Trio生命科学客户和合作者不断变化的需求。。

Mia brings more than 25 years of experience commercializing scientific innovation to Trio. Her career path includes launching a division of Dell Computer in Asia Pacific, initiating a Life Science software strategy for Hewlett Packard, and helping PwC accelerate advisory consulting revenue in the healthcare and life sciences sectors.

Mia为Trio带来了超过25年的科学创新商业化经验。她的职业道路包括在亚太地区启动戴尔计算机部门，为惠普启动生命科学软件战略，帮助PwC加速医疗保健和生命科学领域的咨询咨询收入。

Most recently, Mia served as the Vice President of Partnerships for Komodo Health..

最近，Mia担任Komodo Health合作伙伴关系的副总裁。。

In addition to her full-time roles, Mia has served on advisory boards of three health-tech startups seeking revenue growth and strategic partnerships. While in her role as CCO at Trio, Mia will continue to serve on the board of Bryleos, an emerging biotechnology company.

除了担任全职职务外，Mia还曾担任三家寻求收入增长和战略合作伙伴关系的健康技术创业公司的顾问委员会成员。在担任三人组CCO的职位时，Mia将继续担任新兴生物技术公司Bryleos的董事会成员。

Widely recognized as a pioneer in the healthcare technology and life sciences spaces, Mia will play a pivotal role in Trio's continued expansion that includes the licensing of high-quality clinical data and unique offerings that support all phases of the biopharmaceutical product lifecycle. Mia's commercial experience and vast international technology and life sciences network will usher in a new phase for Trio..

Mia被广泛认可为医疗保健技术和生命科学领域的先驱，将在Trio的持续扩张中发挥关键作用，其中包括高质量临床数据的许可和支持生物制药产品生命周期各个阶段的独特产品。Mia的商业经验和庞大的国际技术与生命科学网络将为Trio开创一个新阶段。。

'There is enormous opportunity for Trio Health that lies ahead,' said Trio CEO, Brent Clough. 'We are delighted to have found a high-caliber leader in Mia to accelerate our company to its next stage of growth and to help our customers achieve commercial success.'

“前面有三人健康的巨大机会，”Brent Clough三人首席执行官说我们很高兴在Mia找到了一位高水平的领导者，以加快我们公司的下一个发展阶段，并帮助我们的客户取得商业成功

'I have known Trio's CEO Brent Clough for nearly a decade. Trio Health's growth, combined with the leadership of Yoori Lee, President, reflects the evolution of the healthcare sector. I am honored to join Trio and to continue to grow their vision,' said Nease.

“我已经知道Trio的首席执行官Brent Clough近十年了。Trio Health的发展与总裁Yoori Lee的领导相结合，反映了医疗行业的发展。我很荣幸加入Trio并继续增长他们的愿景，“Nease说。

About Trio Health

关于三重奏健康

Trio Health's mission is to improve quality of care and patient outcomes through coordinating the efforts of all patient care stakeholders. Their first-of-its-kind Multi-Disease Platform (MDX) tracks patients throughout the course of their treatment, giving pharmaceutical/biotechnology companies, specialty pharmacies and physicians access to information and opportunities that simply doesn't exist anywhere else.

Trio Health的使命是通过协调所有患者护理利益相关者的努力来提高护理质量和患者结果。他们的第一个多疾病平台（MDX）在整个治疗过程中跟踪患者，为制药/生物技术公司，专业药房和医生提供其他地方根本不存在的信息和机会。

Learn more at www.triohealth.com..

Learn more at www.triohealth.com..

CONTACT: Abby Dawson, abby.dawson@triohealth.com

Abby Dawson，abby.dawson@triohealth.com

SOURCE Trio Health

源三重健康